Panelists discuss how expectations for treatment outcomes can become more positive over time through experience with multiple therapies, staying informed about clinical trials and new treatments, and ...

Patients with NSCLC did not see a disease-free survival benefit with Imfinzi after surgery compared with taking a placebo. Disease-free survival (DFS; time after diagnosis during which a person shows ...

Healio spoke with Marlyn Mayo, MD, about increased research focused on symptoms of primary sclerosing cholangitis presented at The Liver Meeting, as well as treatments being ...

Factors That Predict Chemotherapy-Induced Myelosuppression in Lymphoma Patients: Role of the Tumor Necrosis Factor Ligand-Receptor System PURPOSE: To determine differences in prognosis between primary ...

Hyperaldosteronism is when one or both adrenal glands release too much of the hormone aldosterone. High blood pressure can result, which could lead to atrial fibrillation, heart attack, or stroke.